Table 7.
Mean CRP and CD4 levels of participants by group and time period.
|
VCO (n = 29) |
CONTROL (n = 28) |
p-value1 | |
|---|---|---|---|
| mean ± SE | mean ± SE | ||
| C-reactive protein (CRP), mg/L | |||
| Baseline | 7.4 ± 2.3 | 8.2 ± 2.6 | 0.81 |
| Midline | 3.3 ± 0.7 | 4.9 ± 1.3 | 0.268 |
| Mean Difference (p-value2) | 4.1 (0.067) | 3.3 (0.161) | 0.808 |
| Baseline | 7.4 ± 2.3 | 8.2 ± 2.6 | 0.81 |
| Endpoint | 2.5 ± 0.5 | 5.1 ± 0.9 | 0.017* |
| Mean Difference (p-value2) | 4.9 (0.029)* | 3.2 (0.217) | 0.597 |
| p-value3 | 0.043* | 0.199 | |
| CD4 | |||
| Baseline | 770.8 ± 46.0 | 728.6 ± 51.8 | 0.543 |
| Midline | 833.1 ± 57.6 | 802.4 ± 49.7 | 0.688 |
| Mean Difference (p-value2) | 62.3 (0.081) | 73.8 (0.051) | 0.815 |
| Baseline | 770.8 ± 46.0 | 728.6 ± 51.8 | 0.543 |
| Endpoint | 835.4 ± 55.0 | 801.2 ± 60.1 | 0.675 |
| Mean Difference (p-value2) | 64.6 (0.107) | 72.6 (0.085) | 0.887 |
| p-value3 | 0.127 | 0.074 |
1
Independent t-test,
2
Paired t-test,
3
Anova with repeated measure (baseline, midline, and endpoint).
*
significant at p < 0.05.